NCT03824561 Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis] Status COMPLETED Phase N/A
NCT03824522 Post Marketing Surveillance Study for ADYNOVATE in South Korea Status COMPLETED Phase N/A
NCT03817320 PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03814005 A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems Status COMPLETED Phase PHASE1
NCT03808493 A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) Tablet Status COMPLETED Phase PHASE1
NCT03807778 A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03802214 Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF(Tumor Necrosis Factor)Therapy Status TERMINATED Phase N/A
NCT03801148 A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release Capsules Status COMPLETED Phase PHASE1
NCT03792672 A Study to Evaluate Central Nervous System (CNS) Pharmacodynamic Activity of TAK-653 in Healthy Participants Using Transcranial Magnetic Stimulation (TMS) Status COMPLETED Phase PHASE1
NCT03771963 Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults Status COMPLETED Phase PHASE3
NCT03763162 Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03759600 Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer Status COMPLETED Phase PHASE2
NCT03759587 Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer Status COMPLETED Phase PHASE2
NCT03748979 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy Status COMPLETED Phase PHASE1
NCT03746652 Safety and Efficacy of Daratumumab in Combination With Ixazomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma Status UNKNOWN Phase PHASE2
NCT03746015 Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults Status COMPLETED Phase PHASE2
NCT03738475 Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease Status COMPLETED Phase PHASE2